Welcome to Pangaea insights

Our collective intelligence provides an unrivalled breadth and depth of knowledge.

Pangaea’s ongoing relationships with key industry stakeholders facilitate continuous updates and dissemination of relevant market intelligence. Check back often for new posts!

Pangaea Express: PMPRB publishes a Discussion Guide

June 28, 2024
The PMPRB has published a Discussion Guide, the next stage towards their updated Guidelines.

Pangaea Express: New Implications to off-patent versions of a patented drug

January 31, 2024
According to a recent Federal Court ruling, PMPRB’s jurisdiction over patented drug prices could also apply to an off-patent drug.

Pangaea Express: Canada Drug Agency Creation

December 13, 2023
The federal government formally announced the creation of the Canadian Drug Agency (CDA), originally identified in the 2019 budget.

Pangaea Express: PMPRB Scoping Paper to Start Guidelines Discussion

November 15, 2023
The PMPRB has posted its Scoping Paper that poses questions to stakeholders to start the first phase of consultations on its new Guidelines.

Pangaea Express: Douglas Clark, CEO of the pCPA

September 5, 2023
The pCPA Board of Directors recently announced Douglas Clark to be the first CEO of the newly incorporated organization, effective Sept 11.

Pangaea CEO Exchange 2023

August 29, 2023
Last week we hosted an incredible session with Canadian Industry Heads! It was great seeing many familiar faces as well as meeting new colleagues. Thank you to everyone that attended, for sharing your perspectives and insights, and contributing to the day’s success.

Pangaea Express: Health Canada's 2023 Distinction Between Advertising and Other Activities

August 14, 2023
Health Canada has released its updated Guidance on the Distinction Between Advertising and Other Activities.

Pangaea Express: PMPRB Notice and Comment

July 20, 2022
In the period between the coming into force of the new Patented Medicines Regulations and the final publication of a corresponding set of guidelines (“Interim Period”), the PMPRB is proposing to adopt a “status quo” approach to carrying out its regulatory mandate.

Pangaea Express: Quebec Releases Rare Disease Policy

July 15, 2022
The Quebec government has released its provincial Rare Disease Policy. This is the first jurisdiction in Canada to develop a policy for rare diseases that aims to help patients suffering from a rare disease gain better access to diagnosis, health care and treatment.

Pangaea Express: PMPRB releases a statement, April 22, 2022

April 25, 2022
The PMPRB has responded to the statement made April 14, 2022, by the Federal Minister of Health, Minister Duclos regarding the Coming-into-Force of the Regulations Amending the Patented Medicines Regulations.
← Prev
Page 1 of 10
Next →